Clinical Trials

60 enrolled

HER-2 Positive Malignant Carcinoma of Breast

NCT04837820 2026-04-22

The Effect of Acupuncture on Cancer-Related Cognitive Difficulties

270 enrolled

Breast Neoplasms

NCT06027268 2026-04-22

ToPCourT

36 enrolled

Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT06215469 2026-04-22

Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads)

40 enrolled

Alopecia, Breast Neoplasms

NCT02204098 2026-04-21

Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy

27 enrolled

Phase EARLY_PHASE1 Active not recruiting

Breast Neoplasms

NCT02744053 2026-04-21

DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer

96 enrolled

Triple Negative Breast Neoplasms

NCT02957968 2026-04-21

Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca

46 enrolled 21 charts

Phase 3 Active not recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03927027 2026-04-21

Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection

534 enrolled

Breast Neoplasms

NCT03961685 2026-04-21

CALM

Active not recruiting

14 enrolled

Breast Neoplasms

NCT05049746 2026-04-21

Identifying Decision Making Needs for Older Adult Women With Stage I-III Breast Cancer Considering Neoadjuvant or Adjuvant Chemotherapy

95 enrolled

Anatomic Stage I Breast Cancer AJCC v8

NCT06643455 2026-04-21

Mindfulness Intervention for Improving Nutrition in the Digital Kitchen Among Stage I-III Breast Cancer Survivors, MIND Trial

49 enrolled

Anatomic Stage I Breast Cancer AJCC v8

NCT03366844 2026-04-20

Breast Cancer Study of Preoperative Pembrolizumab + Radiation

66 enrolled 16 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03820141 2026-04-20

DTP

51 enrolled 12 charts

Breast Neoplasms

NCT06443359 2026-04-20

Hypofractionated Regional Nodal Irradiation in Breast Cancer

56 enrolled

Breast Neoplasms, Lymphedema

NCT06954532 2026-04-20

ADIE-BC

20 enrolled

Emotional Regulation, Breast Neoplasms, Neoplasms

NCT02326974 2026-04-17

T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA

164 enrolled 19 charts

Breast Neoplasms

NCT02917421 2026-04-17

ART

88 enrolled 10 charts

Breast Neoplasms

NCT03971409 2026-04-17

InCITe

145 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05081492 2026-04-17

CF33-hNIS-antiPDL1 for the Treatment of Metastatic Triple Negative Breast Cancer

9 enrolled

Triple Negative Breast Neoplasms

NCT03377387 2026-04-16

Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer

34 enrolled

Breast Neoplasms

NCT03435952 2026-04-16

Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT

18 enrolled

BreastGenitourinary

Breast Neoplasms, Urologic Neoplasms

NCT04125914 2026-04-16

Weight Management and Health Behavior Intervention in Lowering Cancer Risk for BRCA Positive and Lynch Syndrome Families

384 enrolled

BreastGastrointestinal

Breast Cancer, Familial, Colorectal Neoplasms, Hereditary Nonpolyposis

NCT04267796 2026-04-16

Lifestyle Intervention for the Reduction of Breast Cancer Risk in Normal Weight Women

40 enrolled 9 charts

Breast Neoplasms

NCT02754752 2026-04-15

Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer Treatment

111 enrolled

Breast Neoplasms

NCT02876107 2026-04-15

Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer

42 enrolled

Breast Neoplasms, Edema, Erythema, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03162627 2026-04-15

Selumetinib and Olaparib in Solid Tumors

90 enrolled

Breast Neoplasms

NCT03168737 2026-04-15

18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in Patients

25 enrolled

BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Pancreatic Neoplasms

NCT03546972 2026-04-15

Diabetes Prevention Program With or Without Hunger Training in Helping to Lower Breast Cancer Risk in Obese Participants

51 enrolled

BreastOther

Carcinoma, Intraductal, Noninfiltrating, Obesity, Overweight

NCT04920708 2026-04-14

FAIM

57 enrolled

Breast Neoplasms

NCT03503799 2026-04-13

RESCUE

Active not recruiting

1,191 enrolled

Breast Neoplasms

NCT03650894 2026-04-13

Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients

30 enrolled

Breast Neoplasms

NCT04248257 2026-04-13

Peer Support For Young Adult Women With High Breast Cancer Risk

560 enrolled

Breast Cancer Risk

NCT04522648 2026-04-13

PROTECT

250 enrolled

Breast Neoplasms, Lymphedema

NCT04895761 2026-04-13

Neoadjuvant DPX-Survivac Aromatase Inhibition, Radiotherapy or Cyclophosphamide in HR+HER2- Breast Cancer

6 enrolled

Breast Neoplasms

NCT05215769 2026-04-13

A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic Cancer

243 enrolled 11 charts

BreastThoracic

Breast Neoplasms, Lung Neoplasms, Neoplasm Metastasis

NCT06663787 2026-04-13

HER2 CR

Active not recruiting

50 enrolled

Breast Neoplasms, Neoplasm Metastasis, Neoplasm, Residual

NCT03964532 2026-04-09

TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer

24 enrolled

Breast Neoplasms

NCT06995703 2026-04-09

I-SCREEN Rep

8,490 enrolled

Breast Neoplasms

NCT00579514 2026-04-07

Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients

BreastGastrointestinalGenitourinaryGynecologicThoracic

21,081 enrolled

Urinary Bladder Neoplasms, Breast Neoplasms, Colonic Neoplasms, Kidney Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms

NCT01450020 2026-04-07

Peer Navigator Education in Improving Survivorship Care in African American Breast Cancer Survivors

145 enrolled

Phase 4 Active not recruiting

Breast Neoplasms

NCT04549207 2026-04-07

Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer

240 enrolled

Breast Neoplasms

NCT06604858 2026-04-07

TELESCOPE

31 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07515300 2026-04-07

ARM-LIFE

100 enrolled

Breast Neoplasms

NCT03822312 2026-04-06

A Pilot Study of Tomographic Optical Breast Imaging (DBT-TOBI) to Monitor Response to Neoadjuvant Therapy

30 enrolled

Breast Neoplasms

NCT05703269 2026-04-06

HYPOGRYPHE

BreastCNSDermatologicGenitourinaryThoracic

58 enrolled

Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Small Cell Lung Carcinoma

NCT02295059 2026-04-03

Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention

80 enrolled

Breast Neoplasms

NCT03428802 2026-04-03

Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability

21 enrolled 9 charts

BreastGynecologic

Breast Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms

NCT06874985 2026-04-03

Effectiveness and Impact of the Lived Experience Cancer Awareness Campaign on Screening Participation

BreastGynecologicHead & Neck

1,120 enrolled

Breast Neoplasms, Uterine Cervical Neoplasms, Mouth Neoplasms

NCT06878248 2026-04-03

A Study to Assess CLBR001+ABBV-461 in Subjects With Locally Advanced or Metastatic Breast Cancer

20 enrolled